Soluble rubella E1 envelope protein variants
AssigneeRoche Diagnostics Operations, Inc.
InventorsBarbara Upmeier, Ralf Bollhagen, Alfred Engel, Elke Faatz, Peter Schaarschmidt, Christian Scholz, Toralf Zarnt
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Diagnostics Operations, Inc.
InventorsBarbara Upmeier, Ralf Bollhagen, Alfred Engel, Elke Faatz, Peter Schaarschmidt, Christian Scholz, Toralf Zarnt
Estimating the term…
A soluble rubella E1 antigen variant is disclosed that comprises amino acids 334-409 of the native rubella E1 peptide, but lacks the C-terminal end and at least the transmembrane region and the anchor segment as well as at least the amino acids 143 to 164. Also described is a recombinant DNA molecule encoding the rubella E1 antigen variants which are recombinantly expressed as a chaperone fusion protein, refolded into a soluble and immunoreactive conformation, and further used for the serological detection of anti-rubella antibodies. In addition, also disclosed is a method for the detection, determination and quantification of anti-rubella antibodies of IgG and/or IgM subclass in a sample wherein the rubella E1 antigen is used as a capture reagent and/or binding partner for the antibodies.
A soluble rubella E1 antigen comprising amino acids 334-409 of the native rubella E1 peptide (SEQ ID NO:
Dependencies are inferred from the claim text.